These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21831801)

  • 1. [Exome sequencing and its application].
    Zhang X; Li M; Zhang XJ
    Yi Chuan; 2011 Aug; 33(8):847-56. PubMed ID: 21831801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What can exome sequencing do for you?
    Majewski J; Schwartzentruber J; Lalonde E; Montpetit A; Jabado N
    J Med Genet; 2011 Sep; 48(9):580-9. PubMed ID: 21730106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting Mendelian disorders through exome sequencing.
    Ku CS; Naidoo N; Pawitan Y
    Hum Genet; 2011 Apr; 129(4):351-70. PubMed ID: 21331778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing: a transformative technology.
    Singleton AB
    Lancet Neurol; 2011 Oct; 10(10):942-6. PubMed ID: 21939903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities and challenges of whole-genome and -exome sequencing.
    Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
    BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.
    Hitomi Y; Tokunaga K
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(9):657-676. PubMed ID: 29129848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome versus transcriptome sequencing in identifying coding region variants.
    Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
    Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.
    Chou J; Ohsumi TK; Geha RS
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in medical applications of whole exome/genome sequencing discoveries.
    Marian AJ
    Trends Cardiovasc Med; 2012 Nov; 22(8):219-23. PubMed ID: 22921985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage analysis in the next-generation sequencing era.
    Bailey-Wilson JE; Wilson AF
    Hum Hered; 2011; 72(4):228-36. PubMed ID: 22189465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing as a tool for Mendelian disease gene discovery.
    Bamshad MJ; Ng SB; Bigham AW; Tabor HK; Emond MJ; Nickerson DA; Shendure J
    Nat Rev Genet; 2011 Sep; 12(11):745-55. PubMed ID: 21946919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome-assistant: a rapid and easy detection of disease-related genes and genetic variations from exome sequencing.
    Liu Q; Shen E; Min Q; Li X; Wang X; Li X; Sun ZS; Wu J
    BMC Genomics; 2012 Dec; 13():692. PubMed ID: 23231371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.
    Summerer D; Schracke N; Wu H; Cheng Y; Bau S; Stähler CF; Stähler PF; Beier M
    Genomics; 2010 Apr; 95(4):241-6. PubMed ID: 20138981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing: capture and sequencing of all human coding regions for disease gene discovery.
    Priya RR; Rajasimha HK; Brooks MJ; Swaroop A
    Methods Mol Biol; 2012; 884():335-51. PubMed ID: 22688718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme-phenotype genome-wide association study (XP-GWAS): a method for identifying trait-associated variants by sequencing pools of individuals selected from a diversity panel.
    Yang J; Jiang H; Yeh CT; Yu J; Jeddeloh JA; Nettleton D; Schnable PS
    Plant J; 2015 Nov; 84(3):587-96. PubMed ID: 26386250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategies of genome-wide association study based on high-throughput sequencing].
    Zhou J; Pei Z; Chen Y; Chen R
    Yi Chuan; 2014 Nov; 36(11):1099-111. PubMed ID: 25567868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease gene identification strategies for exome sequencing.
    Gilissen C; Hoischen A; Brunner HG; Veltman JA
    Eur J Hum Genet; 2012 May; 20(5):490-7. PubMed ID: 22258526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of genomic copy number alteration emphasizing a restriction site-based strategy of genome re-sequencing.
    Zheng C; Miao X; Li Y; Huang Y; Ruan J; Ma X; Wang L; Wu CI; Cai J
    Bioinformatics; 2013 Nov; 29(22):2813-21. PubMed ID: 23962614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.